Today’s Solutions: November 29, 2024

For too long, migraines have been a black spot in medical research. Now sufferers of the condition can have hope after a new antibody treatment developed specifically for migraine prevention has just completed Phase III human clinical trials with remarkably positive results. In the study, respondents reported a 50 percent reduction in monthly migraine days. 

Solutions News Source Print this article
More of Today's Solutions

6 tips to keep your houseplants thriving during the colder months

The summer has passed and you’ve kept your houseplants alive during the hottest months of the year. Bravo! Now we’re entering the darker, colder ...

Read More

Grief part II: What to say to someone who is grieving

Being there for someone who is grieving can be intimidating and overwhelming. This is true for those who have not experienced deep loss before, ...

Read More

Revolutionary CBD coating keeps fruit fresh and reduces food waste

In a groundbreaking development, Thai researchers pioneered an invisible and edible coating infused with cannabidiol (CBD), presenting a viable answer to the troublesome problem ...

Read More

The oral wellness step you’re probably skipping: the art of gum massage

As a functional dentist, Dr. Meghna Dassani promotes an often-overlooked technique that goes beyond brushing and flossing: gum massaging. Her theory is that "regularly ...

Read More